Spectral Medical Inc.
EDT.TOTSXHealthcare● Active
$1.38
$-0.03(-2.13%)
Market Cap$404918208
P/E Ratio—
52W High$1.84
52W Low$0.77
Spectral Medical Inc. (EDT.TO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EDT.TO · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 8, 2026EPS Actual
-$0.01
Est. -$0.01 · +0.0%
Revenue
$0.00B
Est. $0.00B · +18.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 8, 2026
After Market Close
▲ Beat Revenue✓ 2-Quarter EPS Beat Streak
EDT.TO reports quarterly as a TSX-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.84B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.84B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 7, 2026 | -$0.01 | — | — | — | $0.00B | — |
| — Q2 FY2026 | May 8, 2026 | -$0.01 | -$0.01 | +0.0% | $0.00B | $0.00B | +18.2% |
| — Q1 FY2026 | Mar 26, 2026 | -$0.01 | -$0.01 | +0.0% | $0.00B | $0.00B | -29.4% |
| ▼ Q4 FY2025 | Nov 7, 2025 | -$0.01 | -$0.11 | -1000.0% | $0.00B | $0.00B | +25.0% |
| — Q3 FY2025 | Aug 8, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2025 | May 9, 2025 | — | -$0.04 | — | $0.00B | — | — |
| — Q1 FY2025 | Mar 27, 2025 | — | $0.01 | — | $0.00B | — | — |
| — Q4 FY2024 | Nov 8, 2024 | — | -$0.04 | — | $0.00B | $0.00B | +37.5% |
Q3 FY2026
Aug 7, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 8, 2026
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+0.0%
Revenue
$0.00B
Q1 FY2026
Mar 26, 2026
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+0.0%
Revenue
$0.00B
Q4 FY2025
Nov 7, 2025Miss
EPS Actual
-$0.11
EPS Est.
-$0.01
EPS Surpr.
-1000.0%
Revenue
$0.00B
Q3 FY2025
Aug 8, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
May 9, 2025
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Mar 27, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 8, 2024
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q1 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2025 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2025 | $-0.01 | $-0.01 | $-0.01 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 8, 2026 | +0.0% | $1.36 | $1.43 | +5.15% |
| ▲ Q1 FY2026 | Mar 26, 2026 | +0.0% | $1.46 | $1.43 | -2.05% |
| ▼ Q4 FY2025 | Nov 7, 2025 | -1000.0% | $1.44 | $1.43 | -0.69% |
| — Q3 FY2025 | Aug 8, 2025 | — | $0.82 | $0.81 | -1.22% |
| — Q2 FY2025 | May 9, 2025 | — | $0.87 | $0.88 | +1.15% |
| — Q1 FY2025 | Mar 27, 2025 | — | $0.74 | $0.75 | +1.35% |
| — Q4 FY2024 | Nov 8, 2024 | — | $0.59 | $0.56 | -5.08% |
| — Q3 FY2024 | Aug 9, 2024 | — | $0.60 | $0.63 | +5.00% |
Q2 FY2026+5.15%
Report Date
May 8, 2026
EPS Beat/Miss
+0.0%
Price Before
$1.36
Price After
$1.43
Q1 FY2026-2.05%
Report Date
Mar 26, 2026
EPS Beat/Miss
+0.0%
Price Before
$1.46
Price After
$1.43
Q4 FY2025-0.69%
Report Date
Nov 7, 2025
EPS Beat/Miss
-1000.0%
Price Before
$1.44
Price After
$1.43
Q3 FY2025-1.22%
Report Date
Aug 8, 2025
EPS Beat/Miss
—
Price Before
$0.82
Price After
$0.81
Q2 FY2025+1.15%
Report Date
May 9, 2025
EPS Beat/Miss
—
Price Before
$0.87
Price After
$0.88
Q1 FY2025+1.35%
Report Date
Mar 27, 2025
EPS Beat/Miss
—
Price Before
$0.74
Price After
$0.75
Q4 FY2024-5.08%
Report Date
Nov 8, 2024
EPS Beat/Miss
—
Price Before
$0.59
Price After
$0.56
Q3 FY2024+5.00%
Report Date
Aug 9, 2024
EPS Beat/Miss
—
Price Before
$0.60
Price After
$0.63
Avg Beat Reaction+1.55%
Avg Miss Reaction-0.69%
Beat Rate2 / 8 quarters
Largest Move+5.15% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EDT.TO ends December
Spectral Medical Inc. (EDT.TO) most recently reported earnings on May 8, 2026 for Q2 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of $-0.01). EDT.TO has beaten EPS estimates for 2 consecutive quarters. The next EDT.TO earnings date is expected around September 1, 2026.
Each quarter, investors track EDT.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EDT.TO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EDT.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EDT.TO earnings · 4 questionsSpectral Medical Inc.'s next earnings report is expected around September 1, 2026. EDT.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EDT.TO historically reports after market close (AMC).
EDT.TO earnings datewhen is EDT.TO earningsEDT.TO next earnings datewhen does EDT.TO report earningsEDT.TO earnings calendar
▸ Source: FMP · Spectral Medical Inc. SEC filings · US GAAP · Spectral Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026